Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal CarcinomaYe‐Lin Liang, Jing‐Ping Yun, Ning Zhang et al.|JAMA|2025Cited by 67
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal CarcinomaYusheng Jie, Cheng Xu, Xiaoyu Liang et al.|JAMA|2025Cited by 26
Diabetes, Prediabetes and the Survival of Nasopharyngeal Carcinoma: A Study of 5,860 PatientsPu‐Yun OuYang, Fang-Yun Xie|PLoS ONE|2014Cited by 10